Abstract
Aptamers developed for applications in cancer therapy can improve the efficacy of drug treatment and enhance imaging. Aptamers for these purposes are generated from a process known as SELEX (systematic evolution of ligands by exponential enrichment), or, more precisely when biological cells are used, cell-based SELEX. Aptamers provide a highly target-specific means of transporting drugs to cancer cells. Improved imaging is also possible when aptamers are coupled with micelles, nanomaterials, or hydrogels. These aptamer conjugates show great ability as molecular probes in a variety of applications.
| Original language | English |
|---|---|
| Title of host publication | Supramolecular Chemistry |
| Publisher | wiley |
| Pages | 1-8 |
| Number of pages | 8 |
| ISBN (Electronic) | 9780470661345 |
| ISBN (Print) | 9780470746400 |
| DOIs | |
| Publication status | Published - 1 Jan 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- aptamers
- cancer cells
- conjugation
- drug development
- molecular conjugate
Fingerprint
Dive into the research topics of 'Aptamer Moieties in Biochemical Applications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver